Marc Banjak
Vermogen: 35 000 $ op 31-08-2026
Vermogen: 35 000 $ op 31-08-2026
Marc A. Banjak is currently Chief Legal Officer at iBio, Inc. since 2025.
Formerly, Mr. Banjak was General Counsel at Istari Oncology, Inc., General Counsel at Dova Pharmaceuticals, Inc. from 2017 to 2021, and a Member of The Colorado Bar Association.
Education includes undergraduate studies at Franklin & Marshall College and graduate studies at Sturm College of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IBIO, INC. 0,07% | 26-03-2026 | 25.000 ( 0,07% ) | 31 750 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IBIO, INC. | Algemeen Adviseur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-04-2021 |
The Colorado Bar Association | Corporate Officer/Principal | - |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Colorado Bar Association | |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Sturm College of Law
Sturm College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau